a r t i c l e s Platelets, unlike other transplantable tissues or cell types, do not tolerate refrigeration and disappear rapidly from the circulation if subjected to chilling before transplantation [1] [2] [3] . Thus, platelets for transfusion are stored at room temperature. Since the routine implementation of platelet transfusions in clinical practice in the 1950s, improvements in platelet collection and handling techniques have greatly increased the quality and safety of platelet products. However, the risk of bacterial infection transmitted through platelet concentrate transfusions is estimated to be 50 times higher than for transfusion of refrigerated red blood cell products 4, 5 . Bacterial sepsis is currently considered the major risk factor for transfusion-transmitted disease. Thus, regulatory agencies limit blood storage to 5 d, and this short shelf life severely compromises platelet inventories and creates chronic shortages 6, 7 . Cold storage of red blood cell units suppresses bacterial contamination. Presumably, platelet refrigeration would also minimize the risk of transfusion-mediated bacteremia, permitting extended storage time and reducing the number of outdated products. However, cold storage per se does not prevent bacterial or viral contamination of donated blood. A combination of cold storage and virus inactivation technology, however, could reduce bacterial and viral growth 8 , eliminating severely compromised platelet inventories and chronic platelet shortages.
We recently found that β 2 integrins on hepatic resident macrophages (Kupffer cells) selectively recognize irreversibly clustered glycans β-GlcNAc-terminating immature glycans on GPIb receptors on short-term (≤4 h)-cooled (0 °C) platelets, leading to their rapid clearance from the circulation 2 . Capping surface β-GlcNAc residues by enzymatic galactosylation with endogenous enzymes prevents short-term-cooled mouse platelet clearance and inhibits the ingestion of chilled human platelets by human macrophage-like cells in vitro 9 , providing a simple method to achieve human chilled platelet survival. For logistical reasons, in our early studies we used isolated platelets and, for clearance studies, did not store mouse platelets for longer than 2 h. In contrast, platelets for transfusion are stored for days as platelet-rich plasma. In a phase 1 clinical trial in which autologous, radiolabeled, galactosylated apheresis platelets refrigerated for 48 h were transfused into human volunteers, the galactosylation procedure did not extend platelet circulation time 10 . Subsequently, we found that, just as with human platelets stored in plasma, galactosylation has no effect on the survival of long-term-refrigerated (≥48 h) mouse platelets 10 . The decision to use 48 h of cold storage in the phase 1 clinical trial 10 was based on a study showing that prolonged refrigeration (12 h ) is necessary to induce accelerated clearance of platelets refrigerated in plasma 3 . In addition, temperature-induced changes, such as microtubular disassembly, become irreversible with >24 h of cooling 11, 12 .
Using the mouse transfusion model, we now dissect the clearance mechanism for platelets refrigerated for ≥48 h. We have found that, as with short-term cooling, platelets refrigerated for 48 h in plasma (designated throughout the manuscript as long-term-refrigerated platelets, or 4 °C platelets) are removed from the recipients' circulation by the liver 13 ; unexpectedly, this removal is mediated 1 2 7 4 volume 15 | number 11 | november 2009 nature medicine a r t i c l e s refrigeration increases the density and concentration of exposed β-galactose (β-gal) residues on platelet glycoproteins, specifically on GPIb-α and its major ligand von Willebrand factor (vWF), such that hepatocytes effect clearance mediated by their Asgr-1 and Asgr-2 receptors. These findings again link glycan exposure with a lectin-mediated platelet clearance mechanism.
RESULTS

Clearance of refrigerated platelets is mediated by hepatocytes
Mouse platelets refrigerated in plasma for 48 h and injected into wild-type (WT) mice are cleared rapidly from the circulation independent of α M β 2 integrin receptors on macrophages 10 , indicating the presence of other clearance mechanisms. Approximately 50% of biotinylated long-term-refrigerated ( Fig. 1a) or 111 indium-labeled ( Fig. 1b ) platelets were cleared within 2 h after platelet infusion, as previously shown for fluorescently labeled platelets 10 . The diminished recovery and survival of long-term-refrigerated biotinylated platelets did not reflect a loss of platelet labeling, as platelet biotinylation was stable at 4 °C for at least 48 h ( Fig. 1a) . As expected, fresh roomtemperature (22 °C) biotinylated ( Fig. 1a) (22 °C) or 48-h (4 °C) stored biotinylated platelets were 78.0 ± 12% and 60.2 ± 9.25%, respectively. We next investigated the tissue fate of long-term-refrigerated platelets transfused into recipient mice. The major destination of 111 indium-labeled long-term-refrigerated platelets was the liver (Fig. 1b) , followed by the spleen and lungs, whereas fresh roomtemperature platelets are removed equally by both the spleen and liver 2, 14 . To our surprise, 5 min after transfusion, biotinylated longterm-refrigerated platelets associated with hepatocytes ( Fig. 1c) and not with liver-resident macrophages, as shown previously for short-term-cooled platelets 2 . The intensity of biotin labeling of hepatocytes was variable ( Fig. 1c) , most likely reflecting variable platelet accessibility to the hepatocyte apical surface as blood flows through the hepatic sinusoids, resulting in differential binding and uptake of platelets by hepatocytes. We found biotinylated longterm-refrigerated platelets in hepatocytes as early as 5 min after transfusion ( Fig. 1c,d) . In sections of livers isolated 30 min after platelet infusion, quantification of platelet ingestion revealed four-to sixfold more hepatocytes containing biotin after infusion of long-term-refrigerated platelets (4 °C) compared to infusion of fresh platelets (22 °C) (P < 0.001; Fig. 1d ). At these time points, we found few biotinylated platelets in recipient livers after infusion of fresh platelets ( Fig. 1c,d) .
In spleen, biotin staining was associated only with the macrophagecontaining red pulp after the infusion of either freshly isolated or long-term-refrigerated platelets ( Fig. 1c) . We found a slightly higher (twofold) number of biotin-positive cells in spleens removed from mice 30 min after transfusion with fresh platelets compared to infusion of long-term-refrigerated platelets ( Fig. 1d ).
HepG2 cells ingest long-term-refrigerated human platelets in vitro
The unexpected finding that hepatocytes contain transfused platelets in situ led us to investigate whether cultured hepatocyte cell lines (HepG2 cells) are also capable of ingesting human platelets in vitro. We added isolated and labeled platelets to cultures of HepG2 cells and determined the degree of binding and ingestion by flow cytometry ( Fig. 2a) . Human platelets avidly bound the surface of HepG2 cells and were internalized ( Fig. 2b) . Platelet binding to HepG2 cells was enhanced by cold storage by ~10% ( Fig. 2a) . However, human platelet ingestion by HepG2 cells was increased by approximately fourfold by long-term cold storage ( Fig. 2b) . Because HepG2 cells do not express α M β 2 receptors ( Fig. 2c) , which we reported previously as being able to recognize short-term-cooled platelets 2 , it is therefore not unexpected that short-term cooling did not enhance platelet uptake by HepG2 cells (Fig. 2b) . Platelet ingestion by hepatocytes was inhibited by cytochalasin D (Fig. 2b) , showing that it requires mobilization of the hepatocyte actin cytoskeleton. These in vitro results confirm our in situ finding that hepatocytes can ingest long-term-refrigerated platelets.
Contribution of macrophages to refrigerated platelet clearance
To assess the relative importance of hepatocytes and macrophages in platelet clearance, we purged recipient mice of mature hepatic and splenic macrophages by injecting toxic clodronate-encapsulated liposomes before transfusion of fresh, short-term-or long-term-refrigerated and/or galactosylated platelets 15, 16 . After clodronate-liposome treatment, no macrophages were detected with the macrophagespecific marker F4/80 (data not shown). We determined initial platelet recovery and survival times in these mice and compared them to mock-treated recipients ( Table 1) . We set the 5-min recoveries of fresh platelets injected into macrophage-depleted mice (119.0 ± 6.35%) to 100% and present the data ( Fig. 2d,e ) relative to this value. Macrophage depletion enhanced the recovery of fresh platelets by 30-40% but had little effect on their survival times ( Fig. 2d,e and Table 1 ). Diminished platelet count increments in untreated mice may reflect the detection of damage inflicted during isolation and is consistently observed after transfusion of fresh platelets into healthy volunteers 10 . As expected, macrophage depletion significantly increased both the count increments and the survival times (P < 0.05) of platelets stored short term at 0 °C ( Table 1) , although the recovery of short-term-cooled platelets was not fully restored, indicating that other cells, presumably, hepatocytes, initially also remove transfused platelets. The difference in short-term-cooled platelet survival after transfusion in mice depleted of macrophages compared to transfusion in control mice was particularly apparent 24 h after platelet transfusion ( Fig. 2) , demonstrating that the circulation of short-term-cooled platelets is markedly improved in macrophage-depleted mice compared to control mice. However, even in macrophage-depleted mice, short-term-cooled platelet survival (~63 h) was slightly shorter when compared to fresh platelet survival (~78 h), indicating that other cells, presumably hepatocytes, participate in the clearance of short-term-cooled platelets ( Fig. 2 and Table 1 ). a r t i c l e s As previously reported 10 , in mice containing macrophages the count increment of long-term-refrigerated platelets was lower compared to that of fresh platelets ( Fig. 2e) . Macrophage depletion showed that only a very small proportion (~20%) of the initial removal of long-term-refrigerated platelets was dependent on macrophage α M β 2 receptors ( Fig. 2d,e ). Galactosylation covers exposed β-GlcNAc residues and deprives macrophage α M β 2 receptors of this platelet ligand 9 . However, the addition of galactose would be expected to promote clearance by galactose-recognizing lectins. Consistent with this notion, galactosylation of long-term-refrigerated platelets substantially decreased (~20%) their recoveries in macrophage-depleted mice. Thus, lectin receptors have dual roles in the clearance of chilled platelets in the liver: depriving the macrophage α M β 2 receptor of its ligand promotes clearance by galactose-recognizing lectins. Notably, the macrophage α M β 2 receptor regulates in part long-term-refrigerated platelet recovery but does not determine their survival time. Consistent with this result, in untreated mice the initial recovery of galactosylated long-term-refrigerated platelets was reduced by ~15% compared to nongalactosylated long-term-refrigerated platelets (P < 0.001, Fig. 2e ), as shown previously 10 .
These findings confirm our previous studies 2 showing that after an initial and rapid macrophage-dependent removal of ~40% of transfused platelets independent of storage conditions, the remaining short-term-cooled platelets in the circulation are predominantly cleared by macrophages (Kupffer cells). In contrast, after prolonged refrigeration, hepatocytes become the main removal site of circulating platelets. With prolonged platelet refrigeration, hepatocyte-dependent removal mechanisms increase the rate of platelet clearance. 22 °C Asf at 4 °C Fet at 4 °C a r t i c l e s The Ashwell-Morell receptor in refrigerated platelet clearance We previously reported that short-term-cooled platelets have exposed and clustered β-GlcNAc residues that are recognized and phagocytosed by the α M β 2 hepatic macrophage receptors 9, 17 . In contrast, platelets refrigerated for long periods had higher galactose exposure as evidenced by increased binding of the galactose-recognizing lectins, Ricinus communis agglutinin I (RCA-I) and Erythrina cristagalli agglutinin (ECA) (Fig. 3a) . This result suggests that galactose-recognizing asialoglycoprotein receptors may be involved in their clearance. We therefore investigated whether long-termrefrigerated platelet clearance is mediated by Ashwell-Morell receptors on hepatocytes. Injections of long-term-refrigerated platelets with the Ashwell-Morell receptor competitor asialofetuin into WT mice markedly improved the recovery and survival time of long-term-refrigerated (4 °C) platelets compared to those of fresh room-temperature (22 °C) platelets (Fig. 3b) . In contrast, the recovery and survival time of short-term-cooled platelets were not affected by asialofetuin co-injection (Fig. 3c) . These results indicate that the Ashwell-Morell receptor mediates the initial removal of circulating long-term-refrigerated, but not shortterm-cooled, platelets in vivo. We next evaluated the survival of long-term-refrigerated platelets in mice lacking either the Asgr-1 or Asgr-2 chains of the Ashwell-Morell receptor. Long-term-refrigerated platelets, transfused into mice lacking Asgr-1 or Asgr-2, had similar count increments as fresh platelets, and their survival times were almost normalized in either Asgr1-deficient or Asgr2-deficient mice (P < 0.01 and P < 0.001 for Asgr1 −/− and Asgr2 −/− , respectively) ( Fig. 3d and Table 1) . Therefore, the removal of longterm-refrigerated platelets is mediated by Ashwell-Morell receptors on hepatocytes. The survival time of fresh platelets was also significantly enhanced in Asgr1-deficient (P < 0.01) and Asgr2-deficient mice (P < 0.001) ( Fig. 3d and Table 1 ), revealing that hepatocyte Ashwell-Morell receptors routinely survey the platelet surface for galactose exposure 18 .
HepG2 cells expressed both chains (ASGR-1 and ASGR-2) of the Ashwell-Morell receptor but did not express the α M β 2 (CD18/CD11b) receptor (Fig. 2c) . As we observed for mouse platelets, human platelets refrigerated for ≥2 h up to 10 d had significantly more galactose exposure compared to fresh or short-term-cooled platelets, as measured by RCA-I and ECA lectin binding. β-gal exposure peaked after 5 d of refrigeration (Fig. 4a) . In contrast, we observed elevated β-GlcNAc exposure after 2 h of refrigeration (P < 0.001), as measured by succinyl wheat germ agglutinin (sWGA) lectin binding (Fig. 4a) . We observed a slight decrease in sWGA binding after 48 h of refrigeration ( Fig. 4a) , similar to that found for mouse platelets (Fig. 3a) .
To address the role of galactose exposure in platelet uptake in vitro, we tested whether soluble sugars (galactose or β-GlcNAc) inhibit the uptake of long-term-refrigerated platelets by HepG2 cells. The uptake of long-term-refrigerated platelets was significantly (P < 0.01) inhibited by 10 mM galactose, whereas β-GlcNAc was without effect (Fig. 4b) . Asialofetuin, but not fetuin, also significantly inhibited long-term-refrigerated platelet uptake in a dose-dependent manner (P < 0.05 and P < 0.001 for 10 µg ml -1 and 100 µg ml -1 asialofetuin, respectively) ( Fig. 4c) , consistent with the effect of asialofetuin on the survival of platelets in mice transfused with long-term refrigerated mouse platelets (Fig. 3b) . We next tested if human platelets refrigerated for longer periods (5 and 10 d) are taken up by HepG2 cells similarly to 48 h refrigerated platelets. Platelets cooled for 2 h at 0 °C were not ingested by HepG2 cells, whereas prolonged refrigeration led to a significant increase of platelet uptake by HepG2 cells at days 2, 5 and 10 (P < 0.01, P < 0.001 and P < 0.05, respectively) ( Fig. 4d) . Maximal platelet ingestion was observed after 5 d of refrigeration, which correlates with increased β-Gal exposure measured at day 5 (Fig. 4a) . Ingestion of long-term-refrigerated platelets was significantly inhibited by the addition of asialofetuin (100 µg ml -1 ) a r t i c l e s ( Fig. 4c,d) . These findings point to the roles of exposed galactose residues and the Ashwell-Morell receptor in human platelet uptake by cultured HepG2 cells.
Platelet GPIb-α is a counter-receptor for Ashwell-Morell receptors
We next investigated whether GPIb-α, a component of the GPIb-IX-V receptor complex that binds vWF, has a role in the removal of long-term-refrigerated platelets, as we previously reported for short-term-cooled platelets 2 . The extracellular domain of GPIb-α contains 60% of total platelet glycan content in the form of N-and O-linked glycan chains [19] [20] [21] . Two of the putative N-linked glycans are localized within the 45-kDa domain of the GPIb-α extracellular domain 22 . We stripped the 45-kDa domain of the extracellular GPIb-α domain from human and mouse platelets with mocarhagin and O-sialoglycoprotein endopeptidase, respectively 2 , and determined whether its loss affected platelet uptake by HepG2 cells in vitro or platelet survival in recipient mice in vivo. Removal of the extracellular domain of GPIb-α before platelet storage prevented human platelet ingestion by HepG2 cells in vitro (P < 0.001) and significantly improved the recovery and survival of long-term-refrigerated platelets (P < 0.05) injected into WT mice (Fig. 5a,b and Table 1 ) (P < 0.05). These findings implicate recognition of GPIb-α glycans by the Ashwell-Morell receptor as a crucial event in the initiation of platelet clearance. We next determined whether exposed β-GlcNAc and β-gal residues that mediate recognition by the α M β 2 lectin domain and the Ashwell-Morell receptor, respectively, reside on GPIb-α. Binding of peroxidase-labeled sWGA 9 or RCA-I to GPIb-α was readily detectable in displays of total platelet proteins resolved by SDS-PAGE ( Fig. 5) , demonstrating that GPIb-α contains the bulk of glycans with exposed β-gal residues on platelets. Binding of sWGA and RCA-I to GPIb-α was also detectable in GPIb-α immunoprecipitates from fresh mouse platelets (Fig. 5c) . However, after prolonged platelet refrigeration and rewarming, lectin binding to β-GlcNAc and β-gal residues on the GPIb-α polypeptide was markedly increased (Fig. 5c) . We did not observe any binding of RCA-I to the C-terminal region of GPIb-α after treatment of platelets with O-sialoglycoprotein endopeptidase (Fig. 5d) , showing that the bulk of RCA-I-reactive β-gal resides within the N terminus of GPIb-α. A small fraction of the GPIb-α pool, recognized by peroxidase-conjugated RCA-I, remained intact after O-sialoglycoprotein endopeptidase treatment (Fig. 5d) , possibly because some GPIb-α molecules are sequestered in the open canalicular system. Immunoblots of lysates from fresh platelets with peroxidase-labeled RCA-I contained multiple stained bands: one corresponding to GPIb-α ( Fig. 5e) , two polypeptides of lower molecular weights (Fig. 5e ) and a large polypeptide of ~260 kDa (Fig. 5e) . RCA-I lectin binding to the ~260-kDa polypeptide was markedly increased after long-term refrigeration (Fig. 5e) . This platelet-associated protein of 260 kDa has a similar molecular mass as vWF and is likely to correspond to vWF, as shown by immunoblotting with an antibody to mouse vWF (Fig. 5e) .
In accordance with this finding, we detect increased vWF binding to the surface of long-term-refrigerated human and mouse platelets by flow cytometry. Refrigeration of human platelets for 48 h in plasma resulted in increased binding to vWF by sixfold (4.5 ± 0.77% for 22 °C, 31 ± 1.99% for 48 h, 4 °C; P < 0.05). Similarly, long-term refrigeration of mouse platelets in plasma resulted in enhanced binding to vWF (1.1 ± 0.1% for 22 °C to 9.5 ± 0.2% for 48 h, 4 °C; P < 0.01). Normally, GPIb-α is arranged in linear arrays on the surface of fresh resting platelets 23 but aggregates after short-term cooling 2 . Prolonged refrigeration promoted clustering of GPIb-α on the surface of the long-term stored cells ( Fig. 5 f-h) .
DISCUSSION
We show here that transfused platelets stored long-term by refrigeration escape a macrophage-based surveillance system, but are instead removed primarily by the Ashwell-Morell asialoglycoprotein receptor on hepatocytes. This conclusion is based on the following lines of evidence: macrophage depletion in mice substantially improves the survival of transfused platelets cooled for 2 h but does not prevent the clearance of platelets chilled for 48 h; transfused long-term-refrigerated platelets are abundantly found in hepatocytes; and 48 h platelet refrigeration markedly increases β-gal exposure. Two standard values are used to evaluate transfused platelet products: the initial platelet recovery (expected platelet increase 1 h after transfusion) and survival. Platelets refrigerated for 48 h have comparable recoveries and survivals to fresh room-temperature platelets in mice lacking the Asgr-1 or Asgr-2 subunit of the Ashwell-Morell receptor or in WT mice injected with asialofetuin, and in vitro HepG2 cells ingest long-term-refrigerated platelets in culture, an ability that is blocked by asialofetuin treatment. The platelet target of the hepatocyte Asgr-1 and Asgr-2 receptors was revealed to be GPIb-α, as shown by marked improvement of the circulation time of 48-h-refrigerated platelets by removal of the N-terminal domain of GPIb-α.
Our studies point out the importance of a hepatic-based platelet removal system that uses the Ashwell-Morell receptor to recognize defectively sialylated proteins and remove platelets with desialylated glycans on their surface 18 . The idea that hepatocytes might ingest large material has been controversial 24 . Whether hepatocytes also remove senescent platelets remains to be established. Although macrophages are widely regarded as the key phagocytes in platelet removal [25] [26] [27] , we find that refrigerated and fresh roomtemperature platelets are cleared in their absence. Although macrophages do not have a substantial role in determining survival time of transfused platelets, they do regulate platelet count increments after transfusion. Platelet lifespan is ultimately limited by endogenous platelet apoptotic machinery 28 .
Platelets from St3Gal4 −/− mice have exposed galactose on surface glycoproteins because they lack the St3Gal4-encoded sialyltransferase (ST3GalIV) 18, 29 . In long-term-refrigerated and rewarmed platelets, the mechanism of galactose exposure remains to be determined. Release or activation of sialidase activity during storage could cleave terminal sialic acid residues, revealing underlying galactose residues. Evidence supporting this mechanism is the increased binding of galactose-recognizing lectins to platelets. Glycans associated with GPIb-α are the major target of this activity. However, the extent of galactose exposure on refrigerated platelets is less than that present on the surface of St3Gal4 +/− platelets that retain their ability to circulate with normal lifetimes 18, 29 . Hence, other changes in the platelet with cooling might amplify the galactose signal. For example, clustering of GPIb-α subunits, facilitated by cytoskeletal and membrane phase changes 30, 31 , could increase the localized density of galactose or glycan presentation, enhancing lectin avidity and binding. Changes in lipid structure could facilitate protein clustering and facilitate alterations in lipid-glycan density, presentation or both 32, 33 . However, the functional relationship between GPIb-α clustering and platelet clearance by hepatocyte Ashwell-Morell receptor remains to be established. a r t i c l e s In particular, it remains unclear whether proteolytic removal of the N-terminal 45-kDa domain of GPIb-α alters clustering.
How does GPIb-α presentation influence platelet clearance? Although platelets stripped of the extracellular domain of GPIb-α do not circulate when transfused 34 , we show that removal of the N-terminal extracellular 45-kDa vWF-binding domain of GPIb-α from long-term-refrigerated platelets restores their survival and prolongs the survival of fresh platelets 2 . The N-terminal domain of GPIb-α contains di-, tri-and tetra-antennary N-linked glycans 35, 36 , whereas O-linked glycans reside within the C-terminal domain 21, 37 . Removal of the N-terminal 282 residues of GPIb-α from human platelets using the snake venom protease mocarhagin 38 or O-sialoglycoprotein endopeptidase eliminates two putative N-glycan residues, as well as the vWF-binding region of GPIb-α 38 . It is tempting to speculate that most of the exposed β-gal residues reside within N-linked glycans on GPIb-α, as shown previously for β-GlcNAc 10 , and that these changes mediate the recognition and removal of platelets, consistent with the known effects of ligand valency and sugar spacing on glycan binding to hepatic Asgr proteins 24 .
Removal of the 45-kDa domain does not, however, completely rescue the initial recovery of long-term-refrigerated platelets, indicating that other factors influence the initial recovery. Cleavage of the GPIb-α by a disintegrin and metalloproteinase-17 causes a dramatic loss of platelet recovery after transfusion 39 . Loss of GPIb-α after refrigeration and rewarming could modulate the recoveries of long-term refrigerated platelets. Exposure of galactose residues on other highly glycosylated receptors, such as α IIb β 3 , or on platelet-bound vWF, could also affect platelet clearance. In accord with this idea, sialic acid-deficient vWF is cleared by Asgr-1 and Asgr-2 receptors 18 , and cooling increases the association of vWF with platelets. Additionally, others have reported that vWF clearance in general is mediated by macrophages and hepatocytes 40 . Proteolytic removal of the GPIbα N-terminal region deprives GPIb-α of its vWF-binding domain and bound vWF. Whether vWF-glycans contribute to recognition of platelets by Ashwell-Morell receptor remains to be determined.
Our original finding that galactosylation of platelets stored shortterm at 0 °C rescues their circulation is contradictory to the notion that galactose recognition by Ashwell-Morell receptors promotes platelet removal. We hypothesize that β-gal added to exposed β-GlcNAc represents only a very small portion of the total platelet glycans, with the majority remaining fully sialylated. Neuraminidase-treated and transfused mouse and rabbit platelets are removed rapidly 41 , demonstrating the fundamental importance of immature or desialylated glycans in eliciting Asgr lectin-mediated clearance. Here we show that the duration of platelet refrigeration influences the nature of glycan exposed, that is, either β-GlcNAc or β-gal. It is, therefore, not surprising that lectin receptors on macrophages, hepatocytes or both cooperate to remove refrigerated platelets (Supplementary Fig. 1) . Cooperation of multiple hepatic receptors has been shown to occur in the elimination of secretory cancer mucins 42 .
Future studies will investigate whether reglycosylation, that is, a combination of galactosylation and sialylation of immature platelet surface glycans, can rescue refrigerated platelet survival to accommodate their refrigeration for transfusion. Inhibition of sialidase activity could also enhance survival of long-term-refrigerated platelets. The unexpected presence of multiple glycosyltransferases (galactosyltransferases and sialyltransferases) in and on the surface of platelets may have implications for platelet functionality, as suggested previously 43, 44 . It is possible that donor sugars and secreted glycosyltransferases regulate platelet function and survival.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemedicine/. 
ONLINE METHODS
Mice. We used age-, strain-and sex-matched C57BL/J6 WT mice of ages 5 to 7 weeks for all clearance and survival studies (Charles River Laboratories). We maintained and treated mice as approved by the Harvard Medical Area Standing Committee on Animals according to US National Institutes of Health standards as set forth in The Guide for the Care and Use of Laboratory Animals. Asgr1 −/− mice 45 and Asgr2 −/− mice (Jackson Laboratory, stock 002387 46 ) were provided by J.D.M.
Platelet preparation. We collected human venous blood from healthy volunteers by venipuncture into one-tenth of the blood volume of Aster Jandl citrate-based anticoagulant (85 mM sodium citrate, 69 mM citric acid, 111 mM glucose, pH 4.6). We prepared platelet-rich plasma (PRP) by centrifugation at 268g for 20 min at 22 °C. For long-term storage experiments, we stored human platelet concentrates from individual donors (Reaserch Blood Components) at 4 °C for ≤10 d, without agitation. We obtained PRP samples (3 ml) under sterile conditions at days 0, 2, 5 and 10. We collected platelets from the PRP by centrifugation at 834g for 5 min, washed them in platelet buffer (140 mM NaCl, 5 mM KCl, 12 mM trisodium citrate, 10 mM glucose, 12.5 mM sucrose, 1 µg ml -1 prostaglandin E 1 , pH 6.0) (buffer A) by centrifugation (834g for 5 min) and resuspended them in 10 mM HEPES, 140 mM NaCl, 3 mM KCl, 0.5 mM MgCl 2 , 10 mM glucose, and 0.5 mM NaHCO 3 , pH 7.4 (ref.
2) (buffer B).
We obtained approval from the Institutional Review Boards of both Brigham and Women's Hospital and the Harvard Medical School, and informed consent was obtained according to the Declaration of Helsinki.
Platelet temperature and storage protocols. To study the effects of cold on platelet survival, function or both, we incubated isolated platelets for 2 h at ice-bath temperatures, a process designated as short-term cooling or as '0 °C' , or resuspended them in platelet-poor plasma and stored them for 48 h at 4 °C, a process designated as long-term refrigeration or as '4 °C' . We rewarmed all platelets stored in the cold for 15 min at 37 °C before use 10 . With the exception of 111 indium labeling, we performed all labeling procedures and enzymatic digestion of platelets before storage. We used freshly isolated platelets (platelets maintained for a maximum of 2 h at 22 °C) in platelet-poor plasma as controls for all survival experiments, and they are designated as fresh platelets or as '22 °C' .
Histology. We infused mice with 3 × 10 9 biotinylated platelets. We collected their organs 5, 15 and 30 min and 24 h afterward, fixed them in paraformaldehyde, embedded them in paraffin and sectioned them every 3 µm. We visualized the distribution of biotin (biotinylated platelets) with strepavidin-peroxidase conjugate and the ImmunoHisto Peroxidase Detection Kit (PIERCE).
We counterstained sections with H&E according to the manufacturer's recommendations (PIERCE). Quantitative analysis of staining was done in blinded samples. We selected ten tissue sections from mice having similar levels of injected platelets and scored them for hepatocytes and macrophages containing biotinylated platelets.
Macrophage depletion. We depleted mice of phagocytic cells by a single injection of liposomes containing dichloromethylene bisphosphonate (clodronate liposomes) 15, 16 . We injected mice intravenously with 0.02 ml of clodronate liposomes per 10 g body weight 24 h before platelet transfusion. This treatment depletes 99% of Kupffer cells and 95% of splenic macrophages 15, 16 . We stained macrophages with an antibody to mouse F4/80 (SEROTEC, clone CI:A3-1) in tissue sections of clodronate-treated and untreated mice. We prepared control liposomes with PBS in place of clodronate.
Multi-distance spatial cluster analysis (Ripley's K-function). We used K-function analysis to determine whether GPIb-α distribution was random, clustered or dispersed on the membrane of cold versus room-temperature platelets 47 . We visualized GPIb-α with immunogold, and we pasted x and y coordinates of gold particles into Microsoft Excel. We plotted L(r) -r versus the radius r using macros obtained from J.F. Hancock. Values <-1 indicate significant dispersal, whereas values >1 indicate significant clustering.
Statistical analyses.
All data are presented as means ± s.e.m. unless otherwise indicated. Our experiments include imbalanced groups, where the precision of the mean effect depends directly on the sample size; the data are therefore calculated as s.e.m. We analyzed all numeric data for statistical significance using oneway analysis of variance with Bonferroni correction for multiple comparisons, unless otherwise indicated, with Prism software (GraphPad). We considered P values of less than 0.05 as statistically significant. Degrees of statistical significance are presented as * * * P < 0.001, * * P < 0.01 and * P < 0.05.
Additional methods. Mouse blood isolation, PRP preparation, mouse and human labeling, the in vitro HepG2-based platelet ingestion assay, electron microscopy and platelet immunogold labeling, protocols for immunoprecipitations and immunoblotting are detailed in the Supplementary Methods. 
